Stocks analysis

Analysis for CHD

  • 📈 Growth — 26/30
  • 💰 Profitability — 17/20
  • 🏦 Financial Health — 14/20
  • 💵 Valuation — 12/20
  • ⚠️ Risk — 4/10
Overall Score: 75/100

Summary:


📈 Growth & Financial Trajectory

From 8 quarters, CHD shows a stable top line around the mid-1.5B range. The sequence starts near $1.50B in 2024 Q2 and ends near $1.53B in 2026 Q2, a modest gain. Net income moves from negative/low in 2024 to positive, finishing around $202.8M in 2026 Q2, with a peak near $216.3M in 2025 Q3.

💰 Margins & Cash Flow

Gross margin runs in the mid 40s percent, with gross profit of $693.9M on $1.53B revenue in 2026 Q2 yielding roughly a Gross Margin of 45%. Operating income of $276.4M on $1.53B gives an Operating Margin ~18%. Net operating cash flow is robust in several quarters, notably $286.8M from operating activities in 2026 Q2, while investing cash outflows are meaningful (-$328.4M), producing a quarterly net cash flow of -$248.6M.

🛡️ Balance Sheet & Liquidity

The balance sheet remains solid. Current assets are $1,521,700,000 vs current liabilities $1,327,200,000, leaving roughly $194M of working capital. Total assets are $9,105,700,000 and equity attributable to parent is $4,347,800,000, with long-term debt of $2,206,300,000 and total liabilities $4,757,900,000. The mix supports ongoing operations but leverage is nontrivial, and liquidity is comfortable but not excessive.

⚠️ Key Drivers & Risks

  • Drivers: resilient consumer staples demand and CHD brand strength.
  • Risks: input cost and currency exposure; valuation sensitivity to earnings volatility.